CRP and androgen insensitivity syndrome: Currently, studies on the role of high sensitive C-reactive protein (hs-CRP) as a prognostic marker in AIS patients are frequently conducted (Cheng et al., 2023; Pu et al., 2022; Li et al., 2016; Lee et al., 2020), while those focused on serum LDH either independently or in conjunction with increased hs-CRP levels, has been comparatively neglected in the scientific discourse.